Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[New biological treatments for lung cancer].

Revue de pneumologie clinique - 1 Feb 2007

Zalcman G, Richard N, Bergot E

Abstract excerpt

Therapies targeted on cell signal pathways that control cell division and tumor angiogenesis have been developed over the last five years for non small cell lung cancer (NSCLC) with some amazing results, in subgroups of selected patients, predicting more significant success in the upcoming years....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Bevacizumab
Share to Clinical Trials, Phase II as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase III as Topic

Share to Erlotinib Hydrochloride

Share to Forecasting

Share to Gefitinib

Share to Patient Selection

Source

Identifiers

PMID: 17457280
DOI: 10.1016/s0761-8417(07)90085-1

Genes

EGFR
EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17457280-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[New biological treatments for lung cancer].PMID 17457280Read ↗

[New targets and new drugs in thoracic oncology].Semantic proximity Read ↗

From Biology to Therapy: Improvements of Therapeutic Options in Lung Cancer.Semantic proximity Read ↗

[Biomarkers and targeted therapies in non-small cell lung cancer: present and future treatments].Semantic proximity Read ↗

[New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis].Semantic proximity Read ↗

New targets and new mechanisms in lung cancer.Semantic proximity Read ↗

[Targeted therapies in the treatment of non-small cell lung cancer].Semantic proximity Read ↗

[News treatments and survival in lung cancer].Semantic proximity Read ↗

[Responses to targeted therapies: lung cancer].Semantic proximity Read ↗

[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 3. Chemotherapy for patients with non-small cell lung cancer, 2) Driver mutation and molecular-targeted therapy in lung cancer].Semantic proximity Read ↗

[Development of molecular targeted therapies in lung cancers].Semantic proximity Read ↗

[Molecule pathology in the treatment of lung cancer-Interdisciplinary view of the importance in thoracic surgery].Semantic proximity Read ↗

[Research Progress of Angiogenesis Inhibitors Plus EGFR-TKI in EGFR-mutated Advanced Non-small Cell Lung Cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.